Xeris Biopharma logo

Xeris Biopharma Share Price Today

(NASDAQ: XERS)

Xeris Biopharma share price is $4.11 & ₹351.26 as on 18 Apr 2025, 2.30 'hrs' IST

$4.11

0.03

(0.74%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Xeris Biopharma share price in Dollar and Rupees. Guide to invest in Xeris Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Xeris Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Xeris Biopharma share price movements

  • Today's Low: $4.05
    Today's High: $4.20

    Day's Volatility :3.46%

  • 52 Weeks Low: $1.69
    52 Weeks High: $6.07

    52 Weeks Volatility :72.16%

Xeris Biopharma (XERS) Returns

PeriodXeris Biopharma Holdings IncSector (Health Care)Index (Russel 2000)
3 Months
23.05%
-2.8%
0.0%
6 Months
35.64%
-11.0%
0.0%
1 Year
136.21%
-1.9%
0.0%
3 Years
125.82%
-1.5%
-12.9%

Xeris Biopharma (XERS) Key Statistics

in dollars & INR

Previous Close
$4.08
Open
$4.08
Today's High
$4.195
Today's Low
$4.05
Market Capitalization
$632.7M
Today's Volume
$1.9M
52 Week High
$6.07
52 Week Low
$1.69
Revenue TTM
$203.1M
EBITDA
$-15.5M
Earnings Per Share (EPS)
$-0.37
Profit Margin
-27.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-617.16%

How to invest in Xeris Biopharma Stock (XERS) from India?

It is very easy for Indian residents to invest directly in Xeris Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xeris Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xeris Biopharma or XERS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xeris Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xeris Biopharma shares which would translate to 0.208 fractional shares of Xeris Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Xeris Biopharma, in just a few clicks!

Returns in Xeris Biopharma (XERS) for Indian investors in Rupees

The Xeris Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xeris Biopharma investment value today

Current value as on today

₹2,38,548

Returns

₹1,38,548

(+138.55%)

Returns from Xeris Biopharma Stock

₹1,36,207 (+136.21%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Xeris Biopharma (XERS)

0%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Xeris Biopharma Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Xeris Biopharma

  • BlackRock Inc

    7.03%

  • Vanguard Group Inc

    5.13%

  • Geode Capital Management, LLC

    2.18%

  • State Street Corp

    2.17%

  • Rosalind Advisors, Inc.

    2.02%

  • Morgan Stanley - Brokerage Accounts

    1.87%

Analyst Recommendation on Xeris Biopharma

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Xeris Biopharma(by analysts ranked 0 to 5 stars)

Analyst Forecast on Xeris Biopharma Stock (XERS)

What analysts predicted

Upside of 52.07%

Target:

$6.25

Current:

$4.11

Insights on Xeris Biopharma Stock (Ticker Symbol: XERS)

  • Price Movement

    In the last 3 months, XERS stock has moved up by 27.5%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 40.63M → 60.09M (in $), with an average increase of 12.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -15.73M → -5.11M (in $), with an average increase of 207.8% per quarter

XERS Xeris Biopharma Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$203.1M
↑ 23.89%
Net Income
$-54.8M
↓ 11.92%
Net Profit Margin
-27.0%
↑ 10.98%

Xeris Biopharma Technicals Summary

Sell

Neutral

Buy

Xeris Biopharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Xeris Biopharma (XERS) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Xeris Biopharma Holdings Inc logo
-24.86%
35.64%
136.21%
125.82%
125.82%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Xeris Biopharma

Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Organization
Xeris Biopharma
Employees
394
CEO
Mr. John P. Shannon
Industry
Health Technology

Management People of Xeris Biopharma

NameTitle
Mr. John P. Shannon
CEO & Director
Mr. Steven M. Pieper
Chief Financial Officer
Ms. Beth P. Hecht J.D.
Chief Legal Officer & Corporate Secretary
Mr. Paul R. Edick J.D.
Senior Advisor
Mr. Kevin McCulloch
President & COO
Ms. Allison Wey
Senior Vice President of Investor Relations & Corporate Communications
Mr. Brian Conner
SVP of Quality and Chief Compliance & Risk Officer
Ms. Kendal Korte
Senior Vice President of Human Resources
Dr. Anh Nguyen M.B.A., M.D.
Chief Medical Officer

Important FAQs about investing in XERS Stock from India :

What is Xeris Biopharma share price today?

Xeris Biopharma share price today stands at $4.11, Open: $4.08 ; Previous Close: $4.08 ; High: $4.20 ; Low: $4.05 ; 52 Week High: $6.07 ; 52 Week Low: $1.69.

The stock opens at $4.08, after a previous close of $4.08. The stock reached a daily high of $4.20 and a low of $4.05, with a 52-week high of $6.07 and a 52-week low of $1.69.

Can Indians buy Xeris Biopharma shares?

Yes, Indians can invest in the Xeris Biopharma (XERS) from India.

With INDmoney, you can buy Xeris Biopharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Xeris Biopharma at zero transaction cost.

How can I buy Xeris Biopharma shares from India?

It is very easy to buy Xeris Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xeris Biopharma (XERS) be purchased?

Yes, you can buy fractional shares of Xeris Biopharma with INDmoney app.

What are the documents required to start investing in Xeris Biopharma stocks?

To start investing in Xeris Biopharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Xeris Biopharma Stock (XERS)?

Today’s highest price of Xeris Biopharma (XERS) is $4.20.

Today’s lowest price of Xeris Biopharma (XERS) is $4.05.

What is today's market capitalisation of Xeris Biopharma?

Today's market capitalisation of Xeris Biopharma XERS is 632.7M

What is the 52 Week High and Low Range of Xeris Biopharma Stock (XERS)?

  • 52 Week High

    $6.07

  • 52 Week Low

    $1.69

What are the historical returns of Xeris Biopharma (XERS)?

  • 1 Month Returns

    -24.86%

  • 3 Months Returns

    35.64%

  • 1 Year Returns

    136.21%

  • 5 Years Returns

    125.82%

Who is the Chief Executive Officer (CEO) of Xeris Biopharma ?

Mr. John P. Shannon is the current Chief Executive Officer (CEO) of Xeris Biopharma.